Zimmer Biomet Holdings Stock Performance

ZBH Stock  USD 121.31  0.13  0.11%   
The firm maintains a market beta of 0.27, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zimmer Biomet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zimmer Biomet is expected to be smaller as well. Zimmer Biomet Holdings has an expected return of -0.0471%. Please make sure to check out Zimmer Biomet Holdings treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Zimmer Biomet Holdings performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zimmer Biomet Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Zimmer Biomet is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
 
Zimmer Biomet dividend paid on 30th of April 2024
04/30/2024
Begin Period Cash Flow375.7 M
  

Zimmer Biomet Relative Risk vs. Return Landscape

If you would invest  12,561  in Zimmer Biomet Holdings on February 12, 2024 and sell it today you would lose (430.00) from holding Zimmer Biomet Holdings or give up 3.42% of portfolio value over 90 days. Zimmer Biomet Holdings is generating negative expected returns assuming volatility of 1.221% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Zimmer, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Zimmer Biomet is expected to under-perform the market. In addition to that, the company is 1.95 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.12 per unit of volatility.

Zimmer Biomet Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Zimmer Biomet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zimmer Biomet Holdings, and traders can use it to determine the average amount a Zimmer Biomet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0386

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsZBH

Estimated Market Risk

 1.22
  actual daily
10
90% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Zimmer Biomet is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zimmer Biomet by adding Zimmer Biomet to a well-diversified portfolio.

Zimmer Biomet Fundamentals Growth

Zimmer Stock prices reflect investors' perceptions of the future prospects and financial health of Zimmer Biomet, and Zimmer Biomet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zimmer Stock performance.

About Zimmer Biomet Performance

To evaluate Zimmer Biomet Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Zimmer Biomet generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Zimmer Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Zimmer Biomet Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Zimmer's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people.

Things to note about Zimmer Biomet Holdings performance evaluation

Checking the ongoing alerts about Zimmer Biomet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zimmer Biomet Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Zimmer Biomet generated a negative expected return over the last 90 days
Over 90.0% of the company outstanding shares are owned by institutional investors
On 30th of April 2024 Zimmer Biomet paid $ 0.24 per share dividend to its current shareholders
Evaluating Zimmer Biomet's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Zimmer Biomet's stock performance include:
  • Analyzing Zimmer Biomet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zimmer Biomet's stock is overvalued or undervalued compared to its peers.
  • Examining Zimmer Biomet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Zimmer Biomet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zimmer Biomet's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Zimmer Biomet's stock. These opinions can provide insight into Zimmer Biomet's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Zimmer Biomet's stock performance is not an exact science, and many factors can impact Zimmer Biomet's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.